Portfolio company
Epigenica
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Auristone
This company develops epigenomic profiling tools and bioinformatics services for clinicians and researchers to support precision medicine and cancer drug discovery.
Ellis Bio
This company develops bisulfite conversion kits for DNA methylation analysis, serving clinical and academic researchers in the epigenomics and oncology sectors.
Epicrispr
This company develops epigenomic therapies to control gene expression in patients with complex diseases.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Epigenomics
This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.
Epics Therapeutics
This biotechnology company develops small-molecule RNA epigenetic modulators to treat patients with solid tumours and autoimmune diseases.
Biomodal
This company develops multiomics sequencing kits and software for life scientists and clinical developers to analyse genetic and epigenetic data from single DNA samples.
Epitome Therapeutics
This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.
